Literature DB >> 11923495

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Suzanne Mandala1, Richard Hajdu, James Bergstrom, Elizabeth Quackenbush, Jenny Xie, James Milligan, Rosemary Thornton, Gan-Ju Shei, Deborah Card, CarolAnn Keohane, Mark Rosenbach, Jeffrey Hale, Christopher L Lynch, Kathleen Rupprecht, William Parsons, Hugh Rosen.   

Abstract

Blood lymphocyte numbers, essential for the development of efficient immune responses, are maintained by recirculation through secondary lymphoid organs. We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720. Both species were high-affinity agonists of at least four of the five S1P receptors. These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen. S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph. Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923495     DOI: 10.1126/science.1070238

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  565 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.

Authors:  Min Xu; Dan Liu; Li-hong Ding; Kun-ling Ma; Min Wu; Lin-li Lv; Yi Wen; Hong Liu; Ri-ning Tang; Bi-cheng Liu
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

3.  Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.

Authors:  Perry C Kennedy; Ran Zhu; Tao Huang; Jose L Tomsig; Thomas P Mathews; Marion David; Olivier Peyruchaud; Timothy L Macdonald; Kevin R Lynch
Journal:  J Pharmacol Exp Ther       Date:  2011-06-01       Impact factor: 4.030

4.  FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.

Authors:  Xiangfeng Zeng; Tong Wang; Cairong Zhu; Yanxia Ye; Bing Song; Xinqiang Lai; Yaoying Zeng
Journal:  Inflamm Res       Date:  2012-03-10       Impact factor: 4.575

5.  A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).

Authors:  Yong-Moon Lee; Krishnan Venkataraman; Sun-Il Hwang; David K Han; Timothy Hla
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-08-06       Impact factor: 3.072

6.  Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist.

Authors:  Ran Zhu; Ashley H Snyder; Yugesh Kharel; Lisa Schaffter; Qin Sun; Perry C Kennedy; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2007-11-10       Impact factor: 7.446

Review 7.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

8.  B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.

Authors:  Rajesh K Sinha; Chung Park; Il-Young Hwang; Michael D Davis; John H Kehrl
Journal:  Immunity       Date:  2009-02-19       Impact factor: 31.745

9.  Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors.

Authors:  Puneet S Jolly; Meryem Bektas; Kenneth R Watterson; Heidi Sankala; Shawn G Payne; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

Review 10.  Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.

Authors:  Masayuki Nagahashi; Nitai C Hait; Michael Maceyka; Dorit Avni; Kazuaki Takabe; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2013-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.